Santen Pharmaceutical Co., Ltd. (TYO:4536)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Products	291.62B	300.00B	301.97B	279.04B	266.26B
Total	291.62B	300.00B	301.97B	279.04B	266.26B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	146.81B	165.31B	175.61B	177.37B	173.63B
China	30.01B	28.93B	29.86B	21.55B	27.20B
Asia (Exclude China)	33.25B	30.10B	28.67B	24.12B	19.81B
Europe, Middle East and Africa (EMEA)	80.10B	74.32B	64.76B	52.51B	42.90B
Others	1.45B	1.35B	-	-	-
Americas	-	-	3.08B	3.49B	2.72B
Total	291.62B	300.01B	301.97B	279.04B	266.26B

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error